In recent years, an increasing number of studies have shown that in tumor tissues, the high expression level of CCR5 can be used as a biological indicator of poor prognosis of colorectal cancer, prostate cancer, and breast cancer, and has the potential to be introduced to evaluate tumor invasion and metastasis.24, 25. This evidence concerns the gene CCR5 and prostate cancer.